secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-10-02T20:37:14+00:00
Accession:  0001213900-26-106435
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Silo Pharma buys Norsight 'Klone' software IP, paying with warrant for 300,000 shares at $1.51
--------------------------------------------------------------------------------

- Silo Pharma bought software and IP from Norsight Consulting Inc., including source and object code for web-based tools marketed under the 'Klone' brand, plus trademarks and domain names.
- Consideration was a warrant for up to 300,000 shares at $1.51/share (about $453,000 if fully exercised), cashless-exercise, exercisable April 1, 2027 through Sept 30, 2031.
- Seller's shares are locked up for 12 months; the warrant carries a 4.99% beneficial-ownership blocker that Norsight may raise to 9.99% with 61 days' notice.
- Warrant sold under Section 4(a)(2); Nasdaq rules cap issuance at 19.99% of outstanding shares absent stockholder approval. Norsight President Craig North and Silo CEO Eric Weisblum signed.
- Norsight warrants the software is an original creation, malware-free and non-infringing, with open-source code limited to Exhibit B; its total liability is capped at the warrants' fair market value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026106435/0001213900-26-106435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026106435/ea0307598-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-106435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer